Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,294,939
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
29,073,662
-
Shares change
-
+1,837,876
-
Total reported value, excl. options
-
$2,418,393,288
-
Value change
-
+$177,308,511
-
Put/Call ratio
-
66%
-
Number of buys
-
122
-
Number of sells
-
-85
-
Price
-
$83.18
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q1 2019
247 filings reported holding CNMD - CONMED Corp - Common Stock as of Q1 2019.
CONMED Corp - Common Stock (CNMD) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,073,662 shares
of 31,294,939 outstanding shares and own 93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4,186,441 shares), VANGUARD GROUP INC (2,768,841 shares), Capital Research Global Investors (1,901,162 shares), DIMENSIONAL FUND ADVISORS LP (1,496,159 shares), Champlain Investment Partners, LLC (1,433,335 shares), STATE STREET CORP (998,514 shares), GOLDMAN SACHS GROUP INC (810,876 shares), MACQUARIE GROUP LTD (802,995 shares), Point72 Asset Management, L.P. (748,411 shares), and NORTHERN TRUST CORP (602,973 shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.